Employers / Professionnal

Depression and generalized anxiety are among the most costly health problems for employers. Mental illness accounts for 30% of disability claims, translating into $15 to $33 billion annually in Canada†. Depression and anxiety are treatable illnesses; however, more than 50% patients do NOT appropriately follow their antidepressant treatment: they discontinue prematurely, prior to the recommended six-month treatment.

 † Sroujian, C. 2003.  "Mental Health is the Number One Cause of Disability in Canada."  The Insurance Journal (August):8.

Challenge 1: Need to evaluate interventions before implementation : clinical impacts, return on investment, cost effectiveness of the approach.

Challenge 2: Need to plan the evaluation study in terms of future implementations : acceptability, modes of payment (private insurer, employer, partnership)

PERSISTANCE is confidential and during the research study, will be offered free of charge to participating companies. The research project is conducted by a highly qualified research team and has been approved by the Centre Hospitalier de l’Université de Montréal (CHUM) ethics committee. For more information on the study, consult the link Project.

If you wish to have your company participate in the PERSISTANCE research project or obtain more information, please contact the study coordinator : Marie-Eve Alary at 514 890-8000 ext. 14872 or by email, marie-eve.alary@crchum.qc.ca